Strategy for the Optimization of Read-Through Therapy for Junctional Epidermolysis Bullosa with COL17A1 Nonsense Mutation. Sayar SB, Has C. J Invest Dermatol 2024;144:2221-2229.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Sayar SB, Has C. Strategy for the Optimization of Read-Through Therapy for Junctional Epidermolysis Bullosa with COL17A1 Nonsense Mutation. J Invest Dermatol 2024;144:2221-2229.
PMID: 38522573